Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan

被引：0
|
作者：
Nishikimi, Akihiko [1 ]
Nakagawa, Takeshi [2 ]
Fujiwara, Mitsuhiro [1 ,3 ]
Watanabe, Ken [4 ,5 ]
Watanabe, Atsushi [6 ]
Komatsu, Ayane [2 ]
Yasuoka, Mikako [7 ]
Watanabe, Ryota [7 ]
Naya, Masahiro [8 ]
Oshima, Hironori [8 ]
Kitagawa, Yuichi [9 ]
Tokuda, Haruhiko [4 ,8 ]
Kondo, Izumi [10 ]
Niida, Shumpei [11 ]
Sakurai, Takashi [11 ]
Kojima, Masayo [7 ]
Arai, Hidenori [10 ]
机构：
[1] Natl Ctr Geriatr & Gerontol, Res Inst, Biosafety Adm Div, 7-430 Morioka, Obu, Aichi 4748511, Japan
[2] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Social Sci, Obu, Aichi, Japan
[3] Toyohashi SOZO Univ, Sch Hlth Sci, Dept Phys Therapy, Obu, Aichi, Japan
[4] Natl Ctr Geriatr & Gerontol, Res Inst, Bioresource Div, Obu, Aichi, Japan
[5] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Musculoskeletal Dis, Obu, Aichi, Japan
[6] Natl Ctr Geriatr & Gerontol, Res Inst, Equipment Management Div, Obu, Aichi, Japan
[7] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Frailty Res, Obu, Aichi, Japan
[8] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi, Japan
[9] Natl Ctr Geriatr & Gerontol, Dept Infect Control, Obu, Aichi, Japan
[10] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan
[11] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi, Japan
来源：
JOURNAL OF INFECTION | 2023年 / 86卷 / 02期
关键词：
D O I：
10.1016/j.jinf.2022.10.026
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E33 / E35
页数：3
相关论文
共 50 条
  • [21] Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis
    Speer, Claudius
    Toellner, Maximilian
    Benning, Louise
    Klein, Katrin
    Bartenschlager, Marie
    Nusshag, Christian
    Kaelble, Florian
    Reichel, Paula
    Schnitzler, Paul
    Zeier, Martin
    Morath, Christian
    Schmitt, Wilhelm H.
    Bergner, Raoul
    Bartenschlager, Ralf
    Schaier, Matthias
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (04) : 593 - 595
  • [22] Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine REPLY
    Waxman, Jacob G.
    Magen, Ori
    Hernan, Miguel A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 192 - 192
  • [23] Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization
    Lipschuetz, Michal
    Guedalia, Joshua
    Cohen, Sarah M.
    Sompolinsky, Yishai
    Shefer, Galit
    Melul, Eli
    Ergaz-Shaltiel, Zivanit
    Goldman-Wohl, Debra
    Yagel, Simcha
    Calderon-Margalit, Ronit
    Beharier, Ofer
    NATURE MEDICINE, 2023, 29 (05) : 1155 - +
  • [24] Antibody Response After a Fifth Dose (Third Booster) of BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers
    Saiag, Esther
    Gamzu, Ronni
    Padova, Hagit
    Paran, Yael
    Goldiner, Ilana
    Cohen, Neta
    Bomze, David
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [25] CoronaVac or BNT162b2 Vaccine as a Third Dose
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (03) : 360 - 361
  • [26] Humoral and Cellular Immune Responses to a Second Dose of COVID-19 Vaccine BNT162b2 in People Receiving Methotrexate or Targeted Immunosuppression: A Cohort Study
    Mahil, Satveer K.
    Bechman, Katie
    Raharja, Antony
    Domingo--Vila, Clara
    Baudry, David
    Brown, Matt
    Cope, Andrew
    Dasandi, Tejus
    Khan, Hataf
    Lechmere, Thomas
    Malim, Michael
    Meynell, Freya
    Pollock, Emily
    Sychowska, Kamila
    Barker, Jonathan
    Norton, Sam
    Galloway, James
    Doores, Katie
    Tree, Timothy
    Smith, Catherine
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4126 - 4130
  • [27] HUMORAL IMMUNOGENICITY TO A SECOND AND THIRD DOSE OF COVID-19 VACCINE BNT162B2 IN PATIENTS WITH SPONDYLOARTHRITIS RECEIVING SECUKINUMAB: A PROSPECTIVE STUDY
    Elkayam, O.
    Eviatar, T.
    Paran, D.
    Levartovsky, D.
    Kaufman, I.
    Broyde, A.
    Elalouf, O.
    Polachek, A.
    Feld, J.
    Haddad, A.
    Gazzit, T.
    Elias, M.
    Higaz, N.
    Aasi, M.
    Quebe-Fehling, E.
    Alarcon, I.
    Kharouf, F.
    Gertel, S.
    Pel, S.
    Nevo, S.
    Devy, Z.
    Furer, V.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S287 - S287
  • [28] Antibody responses induced by the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in a single community hospital in Japan
    Otsuka, Shinya
    Hiraoka, Kei
    Suzuoki, Masato
    Ujiie, Hideki
    Kato, Tatsuya
    Yokota, Isao
    Yonezawa, Kazuya
    Oguma, Keiji
    Iwashiro, Nozomu
    Kato, Mototsugu
    Ohara, Masanori
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (04) : 539 - 542
  • [29] The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
    Cohen, Idan
    Campisi-Pfinto, Salvatore
    Rozenberg, Orit
    Colodner, Raul
    Bar-Sela, Gil
    ONCOLOGIST, 2023, : e225 - e227
  • [30] HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
    Guarino, M.
    Esposito, I
    Portella, G.
    Cossiga, V
    Loperto, I
    Pignata, L.
    Tortora, R.
    Attanasio, M. R.
    Cennamo, M.
    Capasso, M.
    Terracciano, D.
    Cutolo, F. M.
    Lanza, A. G.
    Lieto, R.
    Di Somma, S.
    Picciotto, F. P.
    Morisco, F.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S106 - S107
12345